#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Acute leukaemia Emphysema Spinal muscular atrophy Mitochondrial myopathy Germ cell cancer Stevens-Johnson syndrome Hypochondroplasia Myelodysplastic syndrome with excess blasts Sickle cell disease Piriformis syndrome Synovial sarcoma Neutropenia Waldenstrom's macroglobulinaemia refractory Follicular lymphoma stage I Congenital generalised lipodystrophy More trials…

    Learn about Rare Diseases

    Uterine leiomyosarcoma – Life with Disease Mantle cell lymphoma stage III Mantle cell lymphoma – Treatment Mucopolysaccharidosis – Diagnostics VEXAS syndrome – Trials in Disease Hyperoxaluria Friedreich’s ataxia – Life with Disease Angiosarcoma metastatic – Life with Disease Glomerulonephritis membranoproliferative – Diagnostics Familial amyotrophic lateral sclerosis More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bimekizumab Tisotumab Vedotin Bjt-778 Fludrocortisone Acetate Lbl-007 Mebeverine Hydrochloride Ixazomib Citrate Other Immunosuppressants Ociperlimab Mepivacaine Hydrochloride Ceftriaxone Zalunfiban Glyceryl Trinitrate Calcium Carbonate Pemetrexed Metreleptin Midazolam Hydrochloride A52 Tolinapant Lactate Suvecaltamide More therapies…

    Learn about Your Condition

    Primary biliary cholangitis Chordoma Richter's syndrome Heparin resistance Acute respiratory failure Arrhythmia Thrombosis Obstructive pancreatitis Double hit lymphoma Acne Cutaneous sarcoidosis Erythema migrans Gaucher's disease type III Autoimmune hepatitis Impaired gastric emptying More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Reproductive and Urinary Physiological Phenomena

  • Study on the Effectiveness and Safety of Mifepristone 50 mg Weekly for Contraception in Women

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Mifepristone
    The Netherlands

  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System vs. Desogestrel Tablets for Preventing Pregnancy in Women

    Not recruiting

    3 1 1 1 1
    Investigated Drugs:
    • Desogestrel
    • Levonorgestrel
    Czechia Germany Hungary Lithuania Poland Romania +2

  • Study on the Effectiveness and Safety of Levonorgestrel Vaginal Delivery System for Preventing Pregnancy in Women

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Levonorgestrel
    Czechia Germany Hungary Lithuania Poland Romania +2

  • Study on the Effects of Letrozole in Reducing Ovarian Volume in Women Undergoing Controlled Ovarian Stimulation for Egg Donation

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Infertility female
    Investigated Drugs:
    • Letrozole
    Spain

  • Study on the Effects of Ethinylestradiol, Levonorgestrel, and Chlormadinone Acetate in Hormonal Contraception for Women Using Oral Contraceptives

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • CHLORMADINONE ACETATE
    • Ethinylestradiol
    • Levonorgestrel
    Austria

  • Study on Ovulation Inhibition with Levonorgestrel Tablets for Contraception in Women with Intentional Intake Errors

    Not recruiting

    2 1 1
    Investigated Drugs:
    • Levonorgestrel
    Germany
Previous Page
1 … 3 4 5 6
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!